SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of August 2018
(Commission File Number)
P.V. Nano Cell Ltd.
(Exact name of Registrant as specified in its charter)
Migdal Ha’Emek, Israel 2310102
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-For Form 40-F.
Form 20-F þ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
On August, 2018, P.V. Nano Cell Ltd. (the “Issuer”) published a Fact Sheet.
A copy of the Fact Sheet is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
|99.1||PV Nano Cell Fact Sheet August 2018.|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|P.V. Nano Cell Ltd.|
|Date August 9th, 2018||By:||/s/ Dr. Fernando de la Vega|
Dr. Fernando de la Vega|
Title: Chief Executive Officer